Supplements

A single session of intermittent hypoxia acutely reduces cortisol and leptin while increasing adiponectin levels in people with Parkinson's disease, without disrupting sleep behavior.

In a randomized, double-blind, crossover trial, 15 people with Parkinson's disease (pwPD) and 15 healthy controls underwent one session of intermittent hypoxia (IH) or normoxia. IH acutely decreased cortisol and leptin and increased adiponectin in pwPD, with no significant changes in BDNF, IL-6, or iron. No effects on sleep parameters were observed immediately post-IH, but total sleep time decreased 24 hours after IH versus the immediate post-session measurement in pwPD.

Last updated: Aug 14, 2026•1 RCTs•📖 Read as article →

Evidence Score

Evidence Score42/100
Human RCT★★☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. The acute effects of a single session of intermittent hypoxia on blood biomarker concentrations and sleep parameters in people with Parkinson's disease: A randomized, double-blind, crossover trial.

observational

Faria MH, Kalva-Filho CA, Queiroz VO, Boonstra TW, de Oliveira M, Cursiol JA, Schlenstedt C, Lira FS, Antunes BM, Barbieri FA · Parkinsonism & related disorders (2026)

Participants: N/A
Duration: 24 hours follow-up
Intervention: A single 39-minute session of intermittent normobaric hypoxia (IH) consisting of four 6-minute hypoxic cycles (FiO2 = 0.10) interspersed with three 5-minute normoxic periods, compared to a normoxia protocol (FiO2 = 0.21).
Outcome: Blood biomarker concentrations (BDNF, cortisol, IL-6, iron, leptin, adiponectin) and actigraphy-based sleep parameters (including total sleep time) assessed at baseline, immediately post-session, and at 24-hour follow-up.
Effect Size: N/A
Population: 15 people with Parkinson's disease and 15 sex-matched neurologically healthy individuals.

Result:

PubMed: 42574864DOI: 10.1016/j.parkreldis.2026.108922

Mechanism Graph

Intermittent hypoxia induces a hypoxic dose (SpO2 reduction 5-20%) and activates physiological responses.
↓
Hypoxia modulates endocrine and metabolic pathways, leading to decreased cortisol and leptin and increased adiponectin.
↓
These biomarker changes occur without acute disruption of sleep parameters.
↓
Result: IH acutely alters specific biomarkers in pwPD, suggesting potential neuroprotective or metabolic effects.

Limitations

  • ⚠Small sample size (15 per group) limits generalizability.
  • ⚠Only acute and 24-hour effects were assessed; long-term effects and clinical significance remain unknown.
  • ⚠Sleep parameters were measured via actigraphy, not polysomnography, which may miss subtle changes.
  • ⚠The study did not assess subjective sleep quality or daytime symptoms.

Frequently Asked Questions

What is intermittent hypoxia and how was it applied in this study?▼

Intermittent hypoxia (IH) involves brief episodes of reduced oxygen levels. In this study, participants breathed 10% oxygen for 6 minutes, repeated four times, with 5-minute normoxic breaks, totaling 39 minutes.

Did intermittent hypoxia affect sleep in people with Parkinson's disease?▼

No immediate effects on sleep parameters were observed after IH compared to baseline. However, total sleep time decreased 24 hours after IH compared to the immediate post-session measurement, but this was not compared to normoxia.

Which blood biomarkers changed after intermittent hypoxia?▼

In people with Parkinson's disease, IH acutely reduced cortisol and leptin levels and increased adiponectin levels. No significant changes were found in BDNF, IL-6, or iron.

Is intermittent hypoxia safe for people with Parkinson's disease?▼

The study reports that a single session of IH was safe and effective in inducing hypoxia without disrupting sleep behavior. However, longer-term safety and effects require further investigation.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Faria MH, Kalva-Filho CA, Queiroz VO, Boonstra TW, de Oliveira M, Cursiol JA, Schlenstedt C, Lira FS, Antunes BM, Barbieri FA. "The acute effects of a single session of intermittent hypoxia on blood biomarker concentrations and sleep parameters in people with Parkinson's disease: A randomized, double-blind, crossover trial.." Parkinsonism & related disorders, 2026. PMID: 42574864 DOI: 10.1016/j.parkreldis.2026.108922
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.